GT200100124A - Formas/hidratos polimorficas/os dedihidrocloruroden-[4-(3-cloro-4-flouro-fenilamino)-7-(3-morfolin-4-il-propoxi)-quinazolin-6-il]-acrilamida,procedimientos para suobtencion y su uso en la preparacion de medicamentos que tienen una accion de inhibicio - Google Patents
Formas/hidratos polimorficas/os dedihidrocloruroden-[4-(3-cloro-4-flouro-fenilamino)-7-(3-morfolin-4-il-propoxi)-quinazolin-6-il]-acrilamida,procedimientos para suobtencion y su uso en la preparacion de medicamentos que tienen una accion de inhibicioInfo
- Publication number
- GT200100124A GT200100124A GT200100124A GT200100124A GT200100124A GT 200100124 A GT200100124 A GT 200100124A GT 200100124 A GT200100124 A GT 200100124A GT 200100124 A GT200100124 A GT 200100124A GT 200100124 A GT200100124 A GT 200100124A
- Authority
- GT
- Guatemala
- Prior art keywords
- procedures
- preparation
- suobtention
- dedihydrocloruroden
- hydrats
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 2
- 239000003814 drug Substances 0.000 title 1
- 230000005764 inhibitory process Effects 0.000 title 1
- 108091000080 Phosphotransferase Proteins 0.000 abstract 1
- 208000027418 Wounds and injury Diseases 0.000 abstract 1
- 230000006378 damage Effects 0.000 abstract 1
- 208000014674 injury Diseases 0.000 abstract 1
- 102000020233 phosphotransferase Human genes 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
- C07D239/94—Nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Dermatology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Abstract
LA PRESENTE INVENCION TRATA ACERCA DE FORMAS/HIDRATOS POLIMORFICAS/OS DE DIHIDROCLORURO DE N[4(3CLORO4FLUOROFENILAMINO)7(3MORFOLIN4ILPROPOXI)QUINAZOLIN6IL]ACRILAMIDA, SUS PROCEDIMIENTOS DE PREPARACION Y SU USO EN LA OBTENCION DE MEDICAMENTOS QUE PRESENTAN UNA ACCION DE INHIBICION IRREVERSIBLE DE TIROSINA QUINASA.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10031971A DE10031971A1 (de) | 2000-06-30 | 2000-06-30 | Polymorphe Formen/Hydrate von N-[4-(3-Chlor-4-fluor-phenylamino)-7-(3-morpholin-4-yl-propoxy)-chinazolin-6-yl]-acrylamid Dihydrochlorid, Verfahren zu ihrer Herstellung sowie die Verwendung derselben zur Herstellung von Medikamenten mit irreversibler Tyrosinkinasehemmwirkung |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GT200100124A true GT200100124A (es) | 2002-06-27 |
Family
ID=7647397
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GT200100124A GT200100124A (es) | 2000-06-30 | 2001-06-25 | Formas/hidratos polimorficas/os dedihidrocloruroden-[4-(3-cloro-4-flouro-fenilamino)-7-(3-morfolin-4-il-propoxi)-quinazolin-6-il]-acrilamida,procedimientos para suobtencion y su uso en la preparacion de medicamentos que tienen una accion de inhibicio |
Country Status (39)
| Country | Link |
|---|---|
| US (1) | US20040034022A1 (es) |
| EP (1) | EP1299363A1 (es) |
| JP (1) | JP2004501902A (es) |
| KR (1) | KR20030014403A (es) |
| CN (1) | CN1438994A (es) |
| AP (1) | AP2002002694A0 (es) |
| AR (1) | AR031854A1 (es) |
| AU (1) | AU2001283861A1 (es) |
| BG (1) | BG107352A (es) |
| BR (1) | BR0112082A (es) |
| CA (1) | CA2412535A1 (es) |
| CZ (1) | CZ20024037A3 (es) |
| DE (1) | DE10031971A1 (es) |
| DZ (1) | DZ3342A1 (es) |
| EA (1) | EA005294B1 (es) |
| EC (1) | ECSP024413A (es) |
| EE (1) | EE200200714A (es) |
| GT (1) | GT200100124A (es) |
| HN (1) | HN2001000134A (es) |
| HR (1) | HRP20021019A2 (es) |
| HU (1) | HUP0300900A3 (es) |
| IL (1) | IL152419A0 (es) |
| IS (1) | IS6596A (es) |
| MA (1) | MA26924A1 (es) |
| MX (1) | MXPA03000101A (es) |
| NO (1) | NO20026193L (es) |
| NZ (1) | NZ522001A (es) |
| OA (1) | OA12301A (es) |
| PA (1) | PA8520801A1 (es) |
| PE (1) | PE20020116A1 (es) |
| PL (1) | PL365127A1 (es) |
| SK (1) | SK17642002A3 (es) |
| SV (1) | SV2002000517A (es) |
| TN (1) | TNSN01090A1 (es) |
| UA (1) | UA73588C2 (es) |
| UY (1) | UY26803A1 (es) |
| WO (1) | WO2002000630A1 (es) |
| YU (1) | YU99802A (es) |
| ZA (1) | ZA200209717B (es) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MXPA06012756A (es) * | 2004-05-06 | 2007-01-16 | Warner Lambert Co | 4-fenilamino-quinazolin-6-il-amidas. |
| DE102006000122A1 (de) * | 2006-03-17 | 2007-09-20 | Aug. Winkhaus Gmbh & Co. Kg | Schlüssel für einen Schließzylinder und Schließzylinder für einen solchen Schlüssel |
| WO2017107986A1 (zh) * | 2015-12-25 | 2017-06-29 | 山东轩竹医药科技有限公司 | 喹唑啉衍生物的晶体及其制备方法 |
| WO2017107985A1 (zh) * | 2015-12-25 | 2017-06-29 | 山东轩竹医药科技有限公司 | 喹唑啉衍生物的晶体及其制备方法 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL190489B1 (pl) * | 1996-04-12 | 2005-12-30 | Warner Lambert Co | Nieodwracalne inhibitory kinaz tyrozyny, kompozycja farmaceutyczna je zawierająca i ich zastosowanie |
| AU763626B2 (en) * | 1998-11-19 | 2003-07-31 | Warner-Lambert Company | N-(4-(3-chloro-4-fluoro-phenylamino)-7-(3-morpholin-4-yl- propoxy)-quinazolin-6-yl)-acrylamide, an irreversible inhibitor of tyrosine kinases |
-
2000
- 2000-06-30 DE DE10031971A patent/DE10031971A1/de not_active Withdrawn
-
2001
- 2001-06-15 NZ NZ522001A patent/NZ522001A/en unknown
- 2001-06-15 PL PL01365127A patent/PL365127A1/xx not_active Application Discontinuation
- 2001-06-15 CN CN01811998A patent/CN1438994A/zh active Pending
- 2001-06-15 HU HU0300900A patent/HUP0300900A3/hu unknown
- 2001-06-15 DZ DZ013342A patent/DZ3342A1/fr active
- 2001-06-15 EA EA200300094A patent/EA005294B1/ru not_active IP Right Cessation
- 2001-06-15 IL IL15241901A patent/IL152419A0/xx unknown
- 2001-06-15 YU YU99802A patent/YU99802A/sh unknown
- 2001-06-15 HR HR20021019A patent/HRP20021019A2/xx not_active Application Discontinuation
- 2001-06-15 EE EEP200200714A patent/EE200200714A/xx unknown
- 2001-06-15 UA UA2003010793A patent/UA73588C2/uk unknown
- 2001-06-15 TN TNTNSN01090A patent/TNSN01090A1/fr unknown
- 2001-06-15 EP EP01962739A patent/EP1299363A1/en not_active Withdrawn
- 2001-06-15 KR KR1020027017829A patent/KR20030014403A/ko not_active Withdrawn
- 2001-06-15 BR BR0112082-4A patent/BR0112082A/pt not_active IP Right Cessation
- 2001-06-15 MX MXPA03000101A patent/MXPA03000101A/es unknown
- 2001-06-15 OA OA1200200394A patent/OA12301A/fr unknown
- 2001-06-15 SK SK1764-2002A patent/SK17642002A3/sk unknown
- 2001-06-15 CZ CZ20024037A patent/CZ20024037A3/cs unknown
- 2001-06-15 US US10/312,173 patent/US20040034022A1/en not_active Abandoned
- 2001-06-15 AU AU2001283861A patent/AU2001283861A1/en not_active Abandoned
- 2001-06-15 WO PCT/EP2001/006733 patent/WO2002000630A1/en not_active Ceased
- 2001-06-15 JP JP2002505378A patent/JP2004501902A/ja not_active Withdrawn
- 2001-06-15 CA CA002412535A patent/CA2412535A1/en not_active Abandoned
- 2001-06-15 AP APAP/P/2002/002694A patent/AP2002002694A0/en unknown
- 2001-06-21 PA PA20018520801A patent/PA8520801A1/es unknown
- 2001-06-25 GT GT200100124A patent/GT200100124A/es unknown
- 2001-06-26 PE PE2001000623A patent/PE20020116A1/es not_active Application Discontinuation
- 2001-06-26 HN HN2001000134A patent/HN2001000134A/es unknown
- 2001-06-27 UY UY26803A patent/UY26803A1/es not_active Application Discontinuation
- 2001-06-29 SV SV2001000517A patent/SV2002000517A/es not_active Application Discontinuation
- 2001-06-29 AR ARP010103135A patent/AR031854A1/es unknown
-
2002
- 2002-10-28 IS IS6596A patent/IS6596A/is unknown
- 2002-11-29 ZA ZA200209717A patent/ZA200209717B/en unknown
- 2002-12-04 BG BG107352A patent/BG107352A/bg unknown
- 2002-12-23 NO NO20026193A patent/NO20026193L/no not_active Application Discontinuation
- 2002-12-30 EC EC2002004413A patent/ECSP024413A/es unknown
- 2002-12-30 MA MA26984A patent/MA26924A1/fr unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY2022009I2 (el) | Διυδροναφθυριδινες και σχετικες ενωσεις χρησιμες ως αναστολεις κινασης για τη θεραπεια πολλαπλασιαστικων ασθενειων | |
| ECSP034774A (es) | Pirazolopirimmidinas como agentes terapeuticos | |
| ECSP034773A (es) | Pirazolopirimmidinas como agentes terapeuticos | |
| CO5271715A1 (es) | 7-aza-indolin-2-onas sustituidas en 4 y su uso como inhibidores de proteiuna quinasa | |
| EE200200576A (et) | Oksasooli derivaadid ja nende kasutamine türosiini kinaasi inhibiitoritena | |
| EE200300475A (et) | Türosiini kinaasi inhibiitorid, neid sisaldavad ravimkoostised ja nimetatud ühendid kasutamiseks haiguste ravis | |
| SV2003000633A (es) | Nuevos tiadiazoles y oxadiazoles y su uso como inhibidores de fosfodiesterasa-7 | |
| BR0108347B1 (pt) | composição de cosmético | |
| UY28342A1 (es) | Nuevos compuestos | |
| BRPI0207961A8 (pt) | Uso de análogos de epotilona e capecitabina para fabricar medicamento para tratar tumores cancerosos sólidos e kit compreendendo os referidos compostos. | |
| PT1313489E (pt) | Composicoes farmaceuticas para o tratamento de mucosite, estomatite e sindroma de behcet | |
| AR030185A1 (es) | Glutarimidas sustituidas, su preparacion, medicamentos que las contienen, y uso de las mismas para la fabricacion de medicamentos, especialmente inmunomoduladores, como asi tambien inhibidores de angiopatias y/o enfermedades hematologicas/oncologicas | |
| AR028074A1 (es) | Proceso para la preparacion de dihidroxiesteres y derivados de los mismos | |
| HN2001000281A (es) | Nuevas imidazotriazinonas sustituidas | |
| SI1441770T1 (sl) | Vaginalna formulacija lidokaina za zdravljenje uterine disritmije | |
| AR021843A1 (es) | Derivados de propanolamina sustituidos con heterociclos, procedimiento para su preparacion, y su utilizacion. | |
| BR0210650A (pt) | Tablete, e, uso do mesmo | |
| ECSP034531A (es) | Derivados sustituidos de c-ciclohexilmetilamina | |
| AR030662A1 (es) | Beta-tio-alfa-aminoacidos, procedimiento para su fabricacion, medicamentos que contienen estos compuestos y el uso de los tioaminoacidos para la preparacion de medicamentos | |
| HN2002000278A (es) | Tetrahidroquinolinas | |
| GT200100124A (es) | Formas/hidratos polimorficas/os dedihidrocloruroden-[4-(3-cloro-4-flouro-fenilamino)-7-(3-morfolin-4-il-propoxi)-quinazolin-6-il]-acrilamida,procedimientos para suobtencion y su uso en la preparacion de medicamentos que tienen una accion de inhibicio | |
| BR0016941A (pt) | Derivados de aminometil-fenil-ciclohexanona | |
| PT1268482E (pt) | Piranoindois para o tratamento de glaucoma | |
| AR028122A1 (es) | Nuevos compuestos aminotiolésteres, composiciones farmacéuticas y cosméticas que los contienen y utilizaciones | |
| BRPI0416202A (pt) | formulações inibidoras de fosfodiesterase v |